Christopher Naugle formerly with Cadaret Grant
DID CHRISTOPHER NAUGLE CAUSE YOU INVESTMENT LOSSES? Christopher Naugle Formerly With Cadaret Grant And NYLIFE Securities Has A Customer Complaint For Alleged Broker Misconduct Christopher Naugle Customer Complaint Christopher Naugle has been the subject of at least one customer complaint that we know about, which was filed in the last year to recover investment losses. The allegations made in the FINRA reported customer complaint for investment losses were claimant alleged that he was misled into retiring early and taking his pension in a lump sum and that the investments made in his managed accounts, were not in accordance with his investment objectives. The customer complaint filed against Christopher Naugle’s former employer NYLIFE Securities for investment losses caused by the alleged misconduct is pending as of the date of this report. Christopher Naugle Red Flags & Your Rights As An Investor Of course, Christopher Naugle did not admit to any of the allegations. But regardless of whether an arbitration award was entered, a settlement occurred, or the customer complaint is still pending, the allegations made by customers are red flags which should put all current and former customers of Christopher Naugle at Cadaret Grant and NYLIFE Securities on alert to review carefully the activity and performance of their accounts and question whether Christopher Naugle has engaged in any stockbroker misconduct that may have caused them investment losses. The large number of customer complaints at Cadaret Grant and NYLIFE Securities also raises questions about the brokerage firm’s supervisory practices. If these red flags raise questions, call us and we will inform you of your rights as an investor. File A Claim To Recover Your Investment Losses At Cadaret Grant Due To Christopher Naugle If you have questions about Cadaret Grant, NYLIFE Securities, and/or Christopher Naugle and the management or performance of your accounts, please contact Attorney Pearce for a free initial consultation via email or Toll Free at 1-800-732-2889.
Continue Reading